Abstract
In placental females, one copy of the two X chromosomes is largely silenced during a narrow developmental time window, in a process mediated by the non-coding RNA Xist1. Here, we demonstrate that Xist can initiate X-chromosome inactivation (XCI) well beyond early embryogenesis. By modifying its endogenous level, we show that Xist has the capacity to actively silence genes that escape XCI both in neuronal progenitor cells (NPCs) and in vivo, in mouse embryos. We also show that Xist plays a direct role in eliminating TAD-like structures associated with clusters of escapee genes on the inactive X chromosome, and that this is dependent on Xist’s XCI initiation partner, SPEN2. We further demonstrate that Xist’s function in suppressing gene expression of escapees and topological domain formation is reversible for up to seven days post-induction, but that sustained Xist up-regulation leads to progressively irreversible silencing and CpG island DNA methylation of facultative escapees. Thus, the distinctive transcriptional and regulatory topologies of the silenced X chromosome is actively, directly - and reversibly - controlled by Xist RNA throughout life.
INTRODUCTION
Sex-specific gene expression results in a multitude of sexually dimorphic phenotypes including diseases3–6. One source of such differential expression between XX and XY individuals is the increased expression of some X-linked genes in females, due to their escape from XCI4,7,8. Higher levels of X-linked gene products in females may contribute to sex-specific regulatory programs and account for sex-biased disease predisposition, as shown in the case of autoimmune diseases and immune responses9–11.
While the mechanism underlying the onset of X-chromosome wide gene silencing driven by Xist RNA is increasingly clear, the mechanisms that underlie escape from XCI and the eventual role of Xist have remained obscure12. During early development, Xist RNA spreads in cis and coats one of the two X chromosomes leading to its almost complete transcriptional repression via factors such as SPEN2,13–17. How a subset of “escapee” genes avoid or override this silencing, to be biallelically expressed from both active (Xa) and inactive (Xi) X chromosomes is not known18,19. A small percent of X-linked escapees (~3–7% in mice and ~4–11% in humans19–22) can evade silencing from the very onset of XCI. Such constitutive escape is found in most cell types and individuals and is conserved across different species12,19. By contrast, a larger subset of X-linked genes (at least 20% in human and mice) show variable “facultative” escape, with genes becoming re-expressed following silencing in some tissues, and often variably between individuals23–28. There is increasing evidence that the expression levels of escapees may have a profound impact on sexual dimorphism during development and in sex-biased disease predisposition4,29,30.
Here we set out to test whether Xist plays any role in regulating escapees. Xist RNA is essential to trigger XCI during early development31–33 and the prevailing view has been that it becomes dispensable later on for XCI maintenance in differentiated cells, where multiple layers of epigenetic factors such as DNA methylation, can lock in the silent state of the Xi34–37. In the mouse, Xist is indispensable for the initiation of two waves of XCI12, the first being imprinted (iXCI), leading to silencing of the paternally-inherited X chromosome (Xp) by E3.523,28,38,39. The second wave of XCI is random (rXCI) and occurs in the embryo proper at around implantation (~E5.5)28. Random XCI can be faithfully recapitulated in vitro upon differentiation of mouse embryonic stem cells (mESCs) or by ectopic Xist induction in undifferentiated cells25,40–42. Work on Xist tetracycline-responsive transgenes in mouse ESCs defined a critical time window during early differentiation that marked a shift from Xist-dependent gene silencing to Xist-independent and irreversible XCI, as well as the loss of Xist RNA’s capacity to initiate chromosome-wide gene silencing de novo33. Recent work has shown that Xist RNA initiates XCI in early embryos or ESCs by recruiting its interactor SPEN to the Xi via the A-repeat domain at its 5’ end2,33. Xist RNA also recruits (via hnRNPK) the Polycomb Repressive Complex 1 (PRC1), which is responsible for the Xi-accumulation of H2AK119ub which in turn recruits Polycomb Repressive Complex 2 (PRC2)2,43–45. These repressive epigenetic changes are thought to mediate early maintenance of the inactive state and the accumulation of DNA methylation at CpG islands on the Xi is thought to be the key epigenetic change that fully locks in the maintenance of XCI in differentiated somatic cells46,47.
However, there is increasing evidence, thanks to the use of highly sensitive approaches such as RNA FISH and allelic mRNA detection, that reactivation of silenced Xi genes, or upregulation of gene already partially escaping from XCI, can in fact occur upon Xist loss and that this may impact tissue homeostasis and even contribute to disease37,48–53. In these studies, genes that show reactivation upon Xist loss often correspond to genes that have been shown to escape in other contexts, tissues or cell types37,48–52,54. Both in humans and mice, deletion or depletion of XIST/Xist leads to de-dampening of escapee expression levels from the Xi, where these genes are generally transcribed at lower levels compared to the Xa37,48,49,52. Thus, Xist may actually participate in X-linked gene silencing in adult cells, contrary to previous thinking that its main role is only the initiation of XCI. Nevertheless, the exact causality between Xist RNA levels, the transcriptional activity of escapees, and the factors involved in Xist’s silencing function in differentiated cells is not clear. These are important questions, as over- or under-expression of X-linked escapees can impact development and disease.
RESULTS
Increased Xist RNA levels can silence Xi escapee genes in differentiated cells
To explore the role that Xist RNA levels might play in directly modulating the expression levels of escapees in post-XCI differentiated cells, we assessed whether expression levels of escapees correlate with Xist RNA levels in 21 female NPCs F1 hybrid lines (Mus musculus domesticus (129/Sv) x Mus musculus castaneus (Cast/Eij))55. We first characterised the XCI status in these 21 clones by performing transcriptomic analysis [Extended Data Fig. 1a,b,c]. For each informative X-linked gene we used allele-specific RNA quantifications to calculate its allelic ratio (readsXi/[readsXi+readsXa])56. X-linked genes displaying biallelic expression (allelic ratio of greater than 0.1), were considered escapees (i.e. Xi-specific expression levels contribute to at least 10% of the gene’s total expression) [Extended Data Fig. 1c]. We confirmed substantial variability across different NPC clones in the numbers of escapees per clone, ranging from 48 to 124 genes escaping XCI out of 379 X-linked genes for which we have allelic information, as previously shown [Extended Data Fig. 1d]56,57 and also consistent with human inter-individual data4,7,20–22,58. We assessed whether higher levels of Xist RNA correlate with lower expression levels of escapees chromosome-wide and found a significant negative correlation (p=0.012, correlation test), suggesting that Xist may indeed play a role in tuning the dosage of X-linked escapees on the Xi [Fig. 1a].
To test this directly, we established a system in which we could systematically test the impact of increased Xist RNA levels on the transcriptional activity of escapees in post-XCI NPC cells. We generated clonal NPC lines by in vitro differentiation of female TX1072 mESCs59, which is a polymorphic F1 hybrid line (Mus musculus castaneus (Cast/Eij) x Mus musculus domesticus (C57BL/6)) carrying a doxycycline (Dox) inducible promoter upstream of the Xist endogenous locus on the C57BL/6 X chromosome59,60. TX1072 ESCs undergo random XCI during differentiation in the absence of Dox. We thus generated (without Dox) a heterogenous pool of NPCs in which either the C57BL/6 (B6) or the Cast/Eij (Cast) X chromosome has become inactivated [Fig. 1b]. We then picked single NPC colonies that can be clonally propagated and selected a clonal line (E6) in which the B6 X chromosome is inactivated. In this way, Xist expression levels from the inactive, B6 Xi can be increased by adding Dox to the culture media [Fig. 1b]. We also included two previously described NPC lines (CL30 and CL31) carrying an inactive B6 X chromosome2 [Extended Data Fig. 1e].
NPC clone E6 displays a high degree of escape, with 133 genes showing biallelic expression out of the 446 informative X-linked genes, whereas clones CL30 and CL31 show less escape, with 68 and 50 escapees, respectively [Extended Data Fig. 1e,f]. We checked whether the escapees identified in our NPC clonal lines have been previously shown to escape XCI [Supplementary Table 1; Extended Data Fig. 1g]. We thereby define three categories of genes: (i) ‘constitutive’ escapees (consistently escape XCI in all studies); (ii) ‘facultative’ escapees (variably escape XCI in different contexts) and (iii) ‘NPC-specific’ escapees (escape XCI only in NPC clones so far and behave like facultative escapees). Out of the 133 escapees identified in clone E6, 12 are constitutive escapees and 84 are facultative genes. All 12 constitutive escapees also escape in clones CL30 and CL31 in which we identified 38 and 28 facultative escapees, respectively [Extended Data Fig. 1h]. Only 10 NPC-specific genes were found to escape XCI in all clones; the majority escape variable in different clones [Extended Data Fig. 1g]. Characterising the extent and nature of escape variability across different clones, particularly in light of previous data, is very important to understand whether a specific subset of X-linked genes is sensitive to changes in Xist RNA levels regardless of the cell type or developmental context.
We went on to test whether Xist overexpression directly leads to silencing of these escapees in different NPC lines [Fig. 1; Extended Data Fig. 1]. Xist RNA levels were increased on the Xi by adding Dox to the culture media for 3, 7, 14 and 21 days followed by RNA sequencing [Fig. 1c–f; Extended Data Fig. 2a-e]. Two to three replicates per time point were sequenced, and showed robust data reproducibility [Extended Data Fig. 2a-d]. Xist was efficiently upregulated upon Dox induction leading to a 6.9–7.5-fold enrichment in expression levels [Fig. 1d; Extended Data Fig. 2e]. Increased Xist RNA levels in Dox-treated NPCs were also observed by Xist RNA FISH analysis [Fig. 1c]. Upon Xist induction, the expression levels of escapees were found to be consistently reduced, demonstrating the capacity of Xist RNA to initiate escapee gene silencing in fully differentiated cells, even though this is not during the early developmental time window previously defined for Xist action [Fig. 1e,f; Extended Data Fig. 2a-i]. After 3 days of Xist induction, 78 escapees out of 133 started to show silencing with a significant reduction in allelic ratio of at least 50% (binomial linear model, adjusted p < 0.05), while 89 genes were still expressed from the Xi (i.e. allelic ratio > 0.1). By day 14 and 21 of Dox treatment gene silencing became complete for up to 119 escapees with only 21 genes still showing residual escape (albeit at reduced level) after 21 days of Xist induction [Fig. 1f; Extended Data Fig. 2i].
Allele-specific differential expression analysis of X-linked genes in Dox-treated vs untreated NPCs showed significant downregulation of total levels of most escapees and confirms Xist-mediated silencing in cis only on the Xi, whilst the expression levels of homologous genes on the Xa remain unchanged [Extended Data Fig. 3a-b]. This observation suggests the lack of compensatory mechanisms that control the overall dosage of escapees, at least at the mRNA level [Extended Data Fig. 3a-c]. We also tested whether Xist upregulation affects the expression of autosomal genes. We found that only 3 genes were up-regulated and 13 down-regulated across the rest of the genome, showing that there are very limited effects of Xist upregulation on the expression levels of autosomal genes [Extended Data Fig. 3c].
Changes in allelic ratios of escapees over the Dox time course suggest different silencing dynamics for different categories of escapees [Fig 1.f,g, Extended Data Fig. 2f-h]. To better characterise the silencing dynamics of different escapees upon Xist overexpression in NPCs, we quantified the speed at which escape was lost upon Xist overexpression (silencing half-life); and asked whether after prolonged Dox treatment certain genes retained some expression (residual escape) [Fig. 1h; Extended Data Fig. 4a,b]. Briefly, we fitted two alternative exponential decay models, one in which we estimated the half-life t1/2 of the allelic ratios approaching 0 (full silencing model) and one in which the decay approaches a residual escape level (residual escape model) [Fig. 1h]. For 31 genes (out of 122 with an exponential fit R2 > 0.3), the silencing kinetics were better explained by the model that includes a residual escape term, indicating that for a group of genes full silencing will not be established even after persistent Xist overexpression, while the majority become robustly silenced [Extended Data Fig. 4a]. For both groups, fully silenced and residual escape genes, we found that escapees showed a large variation in silencing speeds, with constitutive escapees being silenced more slowly than NPC-specific and facultative escapee genes, with the latter showing the widest range of silencing kinetics [Fig. 1i]. Similarly, residual escape was more frequent and higher amongst constitutive escapees than amongst facultative and NPC-specific escapees [Fig. 1k; Extended Data Fig. 4a,b].
Finally, we asked whether the expression levels of escapees or their position along the Xi account for the differences found in silencing upon Xist upregulation [Fig. 1j; Extended Data Fig. 4c,d]. We found no correlation between the general expression levels of escapees (Xa + Xi levels) and their efficiency of being silenced upon increased Xist expression (+Dox) [Extended Data Fig. 4c]. Similar results were obtained by taking into account only the Xi-specific expression levels of escapees [Extended Data Fig. 4d]. However, escapees pairs within 100 kb of each other showed more similar half-lives than randomly chosen pairs, implying that neighbouring escapees share similar responses to increased Xist levels [Fig. 1j]. We identified 11 regions with at least 3 escapees along the Xi characterised by different silencing speeds [Fig. 1e,f,j]. Interestingly, region 6 and 7, which include 12 and 13 genes respectively, correspond to neighbouring loci along the X chromosome, yet their dynamics of silencing is rather different, suggesting that proximity alone cannot fully explain the observed differences in silencing speed [Fig. 1e,j]. Altogether, we show that increased Xist RNA has the capacity to directly reduce the expression levels of escapees in post-XCI cells, leading to almost full loss of escape after 21 days of Dox induction in NPCs.
Xist-mediated silencing in NPCs is SPEN-dependent
We asked whether the mechanisms underlying Xist-mediated silencing in NPCs are the same as those that control XCI initiation at the onset of the process in mESCs and during early development when the transcriptional repressor SPEN plays an essential role2. Indeed, SPEN knockout embryos fail to initiate iXCI and phenocopy mutants embryos lacking Xist2,38. To address whether Xist-mediated escapee silencing in post-XCI cells is SPEN dependent, we used two NPCs clones (CL30 and CL31) in which both endogenous Spen alleles are tagged with the AID degron domain. This allows SPEN acute degradation upon addition of the plant hormone auxin (indole-3-acetic acid; IAA) to the culture media2. SPEN was depleted in the two NPC clones for 2 days before inducing Xist upregulation for 3 and 7 days [Fig. 2a]. Depletion of SPEN in absence of Xist upregulation led to moderate upregulation of escapees, confirming that in female NPCs SPEN dampens their expression levels on the Xi, as we previously observed [Extended Data Fig. 5a; Dossin et al., 2020]. Xist was efficiently upregulated upon combined Dox and Auxin treatment, reaching up to 10-fold enrichment compared to untreated NPCs [Extended Data Fig. 5b]. However, in absence of SPEN, the higher levels of Xist RNA did not alter the expression levels of escapees, contrary to the Xist-mediated silencing seen in the presence of SPEN [Fig. 2b, Extended Data Fig. 5a]. Notably, all three categories of escapees were unaffected by Xist in the context of SPEN depletion, suggesting that the capacity of Xist RNA to modulate the expression levels of all escapees in NPCs is strictly SPEN-dependent [Fig. 2c,d]. Our data thus reveal that SPEN is essential for Xist-mediated silencing of escapees in differentiated cells, similarly to the situation during early embryonic development which is when XCI is initially established.
Xist-mediated silencing of escapees leads to loss of TAD-like domains on the Xi
Our previous studies revealed that clusters of facultative escapees reside in TAD-like structures on the inactive X chromosome, which is otherwise devoid of TADs in differentiated cells57,61. However, the relationship between Xist RNA coating, gene silencing, and 3D topology on the inactive X chromosome is not yet fully understood. In particular, whether the topological organisation of escaping clusters is a cause or a consequence of escapee expression, remains an open question.
Here we addressed how chromosome topology responds to changes in transcriptional activity of escapees, upon increased Xist expression with or without SPEN depletion. We performed allele-specific Capture Hi-C analysis of >3 Mb genomic regions encompassing the TAD-like domains previously observed on the Xi in clonal NPCs57 [Fig. 3a,b]. One of these (the ‘Mecp2-Hcfc1 cluster’) spans ~800 kb and includes 19 facultative and 6 NPC-specific escapees [Fig. 1e,f]. In clone E6, all 25 genes escape in this region, whereas in CL30.7 only 10 genes are biallelically expressed [Extended Data Fig. 1e]. The second, ‘Kdm5c cluster’, spans ~500 kb and includes the constitutive escapee Kdm5c together with 12 facultative escapees [Fig. 1e,f]. As expected, we observed a general lack of TADs at silenced genes on the Xi, whereas clusters of escaping genes were organised into 3D TAD-like structures that resemble the topological organisation of the Xa [Fig. 3a,b]. After 7 days of Dox induction, the 3D topology of the Xa at the Mecp2-Hcfc1 cluster remains unchanged [Extended Data Fig. 6a] whereas TAD-like structures at the same locus on the Xi become attenuated, but not completely lost [Fig. 3a]. In particular, escapees that are robustly silenced show more pronounced loss of topological organisation whereas genes that are only dampened but remain transcriptionally active retain their structural organisation [Fig. 3a]. Interestingly, the first group of escapees lies in region 6, characterised by relatively faster gene silencing than neighbouring region 7 which includes escapees showing longer silencing half-life and retaining topological organisation after 7 days of Dox treatment [Fig. 1j; Fig. 3a]. However, by day 21of Xist upregulation most escapees in the Mecp2-Hcfc1 cluster are effectively silenced and TAD-like structures are lost across the entire region [Fig. 3a].
We observed similar results at the Kdm5c cluster [Fig. 3b, Extended Data Fig. 6b]. Here, 7 days of Xist upregulation resulted in efficient silencing of all 11 facultative and NPC-specific escapees in the cluster, although Kdm5c which is a constitutive escapee resists complete inactivation [Fig. 3b]. Similarly to the Mecp2-Hcfc1 cluster, upon Xist upregulation the TAD-like structures encompassing all escapees at this locus are lost. Only a long-range looping interaction upstream of Kdm5c is maintained, probably allowing this locus to engage in long-range contacts with other escapee loci, as previously suggested [Fig. 3b]34,57. These results suggest that the local 3D structures at escapee clusters on the Xi are the result of ongoing transcription at these loci.
Xist RNA has previously been proposed to play a role in shaping the conformation of the Xi, independently of transcription at least in part15,34. To assess whether the effect we saw on X-chromosome structure was due to increased Xist RNA levels or to gene silencing we analysed cells with or without SPEN. We performed allele-specific Capture Hi-C experiments in NPC clone CL30 containing the SPEN-AID degron [Fig. 3c]. No differences in 3D topology on the Xa were observed upon doxycycline (Xist up-regulation) and auxin (SPEN depletion) treatment [Extended Data Fig. 6c]. Inducing Xist upregulation for 21 days while triggering the acute depletion of SPEN results in no loss in local 3D topology of the Xi. Escapee genes within the Mecp2-Hcfc1 cluster remain actively transcribed and organised in 3D TAD-like domains, even though Xist RNA levels are 10-fold higher in Dox-treated cells [Fig. 3c].
Altogether, our results reveal that increased Xist RNA levels only lead to loss of TAD-like structures on the inactive X, in the presence of SPEN as Xist RNA upregulation in the absence of SPEN does not affect the 3D topology of these loci. This demonstrates that Xist RNA is capable of shaping the conformation of the Xi at escapee loci, only in the context of transcriptional repression of X-linked genes.
Silencing of most escapees becomes Xist-independent after prolonged Xist upregulation
Another key question we wished to address was whether Xist-mediated silencing of escapees in NPCs is reversible and strictly dependent on persistent Xist overexpression, or whether silencing eventually becomes irreversible and epigenetically locked in. To address this, we induced Xist upregulation for 3, 7, 14, and 21 days in NPC clone E6 followed by 7 days of washout and we performed RNA sequencing [Fig. 4a–d]. During the time course NPCs continued to actively divide and we did not notice any obvious effect on cell proliferation. After Dox washout Xist expression levels return to the levels found in untreated cells prior to Dox-induced overexpression [Fig. 4b,c]. Our analysis reveals progressive irreversibility of silencing upon longer periods of Xist upregulation, with different escape categories following different dynamics of reactivation after Dox washout [Fig. 4d–f]. After 7 days of Xist upregulation followed by 7 days of Dox washout, 95 escapees out of 133 show reversible silencing and become reactivated (i.e. allelic ratio >0.1 and at least 50% of original escape level), whereas 16 genes are only partially irreversible (i.e. <50% of original escape level) and 22 escapees are irreversibly silenced [Fig. 4f]. Amongst the irreversible genes, 13 genes are NPC-specific and 9 facultative genes [Fig. 4f]. Notably, all 12 constitutive escapees are fully reversible at this time point [Fig. 4f]. After 14 days of Xist upregulation, the repressed state of 57 escapees becomes irreversible when checking after 7 days of washout [Fig. 4f]. Of these genes, 25 are NPC-specific, 30 facultative and 2 constitutive [Fig. 4f]. The number of escapees becoming irreversibly silenced remains mostly unchanged, across all categories after 21 days of Xist induction (compared to 14 days), suggesting that for irreversibly-silenced genes, Xist RNA becomes dispensable after 2 weeks of upregulation [Fig. 4f]. Notably, most constitutive escapees are still fully reactivated upon washout following 21 days of Xist upregulation. Thus, although constitutive escapees are sensitive to Xist RNA levels, they remain resistant to complete XCI [Fig. 4df].
We also investigated whether the observed differences in reactivation across different escapees reflect the differences in silencing dynamics observed in the 21 days Dox time course [Fig. 4g]. We found that escapees that undergo fast silencing upon increased Xist levels are less prone to reactivate, whereas slowly silenced genes tend to retain the capacity to become reactivated, when Xist returns to its basal expression levels [Fig. 4g].
The latter situation is illustrated by the 4 escapees included in group 11, which show the longest silencing half-life and get fully reactivated after 21 days of Dox treatment [Fig. 4g]. On the other hand, gene silencing of escapees in regions 5, 8, and 9 become irreversible after 21 days of Xist upregulation [Fig. 4g]. As we observed for escapee silencing dynamics, the genes in regions 6 and 7 also respond differently to Dox washout, despite being in close proximity to each other on the Xi [Fig. 4g]. Given that gene silencing is largely reversible after 7 days of Xist upregulation at both Hcfc1-Mecp2 and Kdm5c clusters organised in TAD-like structures on the Xi [Fig. 3a,b Fig. 4d], we tested whether reducing Xist to basal levels (Dox washout) would restore their topological organisation. Indeed, the 3D spatial organisation of these loci that is either attenuated or lost after 7 days of Xist upregulation [Fig. 3a,b] becomes re-established when active transcription is restored on the Xi upon Dox washout [Fig. 3d, Extended Data Fig. 6d], whereas the 3D topology of the same loci on the Xa remains unchanged throughout the experiment [Extended Data Fig. 6b]. These data reinforce the observation that the emergence to TAD-like structures at escaping loci is the direct consequence of active gene transcription.
In summary, we showed that in NPCs, silencing of most escapees become irreversible and Xist-independent after 14 days of Xist upregulation, and that constitutive escapees are mostly reversibly silenced by Xist upregulation whilst the other categories of escapees show more variable responses in terms of gene reactivation after Dox washout.
Irreversible silencing of escapees is facilitated by increased promoter methylation
Given the known role of DNA methylation in stably locking in the silent state of genes on the Xi12, we assessed whether irreversible silencing of escapees is accompanied by DNA methylation. On the Xi, promoters CpG islands (GCI) of silent genes - but not of escapees - are hypermethylated, whereas CpG methylation of gene bodies is found at transcribed escapees on both Xa and Xi chromosomes, similar to other active genes in the genome63,64.
We assessed whether increased levels of Xist RNA lead to changes in DNA methylation at escapees and whether this epigenetic feature can account for the transition from reversible to irreversible gene silencing upon Xist overexpression in NPCs. We performed allele-specific DNA-methylation analysis by Next Enzymatic Methyl-seq (EM-seq), after 7 and 21 days of Xist upregulation and Dox washout [Fig. 5a,b]. We found a progressive increase in DNA methylation at CpG-dense regions chromosome-wide upon Xist overexpression, suggesting that prolonged high levels of Xist RNA leads to de novo DNA methylation in NPCs [Fig. 5a]. We also found a significant decrease in DNA methylation at escapee gene bodies on the Xi (compared to silent genes on the Xi, where no change was seen), indicating that as escapees become repressed they acquire the epigenetic features of silenced genes on the Xi (i.e. hypermethylated CpG islands and hypomethylated gene bodies)[Fig. 5a,b]. These changes in DNA methylation at CpG islands and gene bodies of escapees were found to remain unchanged when Xist RNA levels were reduced to basal levels upon Dox washout for 7 days [Fig. 5a,b].
To gain DNA methylation information at a higher resolution and assess the methylation status of CpG islands at promoters of escapees that are either reversibly or irreversibly silenced, we also performed targeted capture methylation sequencing (EM-Cap)65 [Fig. 5c,d]. We focused on the Mecp2-Hcfc1 cluster as it includes escapees that differentially respond to varying Xist RNA levels. To assign CpG islands to promoters of escapees on the Xi we used allele-specific ATAC-seq peaks obtained from clone E6 before inducing Xist upregulation [Fig. 5c,d]. In this way, we were able to observe higher levels of DNA methylation at CpG-dense promoters of escapees that are irreversibly silenced compared to partially irreversible genes after 21 days of doxycycline treatment [Fig. 5c,d]. DNA methylation levels remain stable after doxycycline washout [Fig. 5c,d].
In summary, we show that when increased for at least 14 days Xist RNA levels lead to irreversible silencing of escapees, and this is accompanied by loss and gain of DNA methylation at gene bodies and promoters, respectively. These changes mirror the patterns observed at genes that are robustly and stably silenced during XCI. On the contrary, escapees that remain partially irreversible upon Xist upregulation show a smaller gain of DNA methylation at their promoters and this is reflected by their capacity to become fully re-expressed when basal Xist RNA levels are restored even after 3 weeks of Xist induction.
Xist levels modulate X-linked dosage in vivo
The above studies were all performed on NPC cell lines in vitro. In order to assess whether Xist RNA levels can similarly modulate the expression levels of escapees in vivo, we investigated the impact of increasing Xist expression during preimplantation mouse development. To this end, we used mice that carry a doxycycline-inducible endogenous Xist allele (TX) and the tetracycline-responsive transactivator (rtTA) integrated at the ubiquitously expressed Rosa26 locus60. These mice were originally used to establish the TX1072 mESCs59 and the NPC derivatives used in this study. We crossed TX/Y males heterozygotes for the rtTA transactivator (Xptet/Y; R26rtTA/WT) with wild type Mus musculus molossinus (JF1) females to obtain F1 hybrid embryos, in order to distinguish maternal and paternal alleles [Fig. 6a]. As iXCI always leads to the inactivation of the paternal X chromosome (Xp), this strategy allows us to perform whole embryo RNA-seq [Fig. 6a].
We collected F1 embryos at E2.5 and E3.5 stages during pre-implantation development and cultured them in vitro for 24 hours in the presence of Dox before performing RNA-seq at E3.5 and E4.5, respectively [Fig. 6a]. Given the genotype of TX/Y males, all F1 female embryos inherited the dox-inducible Xist allele but Xist upregulation was induced only in embryos carrying the rtTA transactivator which is essential for the inducible system to work [Fig. 6a]. This system provided us with control embryos in which Xist levels remained unchanged upon doxycycline induction [Fig. 6a]. We selected E3.5 and E4.5 developmental stages to avoid the establishment phase of iXCI, which starts at the 4-cell stage, in order to assess the impact that increased Xist RNA levels have, once iXCI has already occurred [Fig. 6a]38. Indeed iXCI is largely complete by the early blastocyst state (E3.5) with most genes being partially or fully silenced, and some genes escaping XCI23,38.
Increased levels of Xist RNA in female embryos carrying rtTA was detectable by RNA FISH as larger and more intense clouds, similarly to what we observed in doxycycline-treated NPCs [Fig. 6b,c]. Xist upregulation was also observed by whole embryo RNA-seq at E4.5, although we noticed a degree of variability in Xist RNA levels between different embryos and in particular in rtTA negative controls at E3.5 [Fig. 6d]. Principal components analysis (PCA) of X-linked allelic ratios across all sequenced embryos clustered them according to their developmental stage [Fig. 6e]. Notably, rtTA positive embryos show lower X-linked allelic ratios when compared to their stage-matching controls at E3.5 and E4.5, suggesting that increased Xist RNA levels lead to higher levels of silencing of X-linked genes that are expressed from the Xi at these stages of iXCI in vivo [Fig. 6f].
To address the impact of Xist upregulation on the expression levels of escapees on the Xi, we focused on E4.5 embryos as XCI is complete at this stage, with 203 genes being inactivated out of 343 informative genes compared with 133 inactivated genes at E3.5 [Fig. 6g] (median allelic ratio >0.1). We detected 135 escapees at E4.5 (i.e. allelic ratio >0.1 in at least 50% of embryos) [Fig. 6g,h]. These genes include 9 constitutive escapees and 87 facultative escapees [Fig. 6h]. Eight of the constitutive escapees identified in embryos and 61 of the facultative genes were also detected in NPCs, respectively [Fig 6h]. Out of the 31 NPC-specific escapees identified in NPCs, 13 escaped XCI in embryos as well, confirming their facultative nature. We also identified 27 embryo-specific genes that were reported as inactivated genes in our reference list [Supplementary Table 1]. Upon Xist upregulation most escapees become downregulated on the Xi, with 117 genes out of 135 showing decreased expression levels [Fig. 6h]. Similarly to what we observed in NPCs, different categories of escapees showed different responses to increased Xist RNA levels [Fig. 6h,i]. Constitutive escapees are less sensitive to Xist upregulation once again highlighting their intrinsic capacity to evade Xist-mediated silencing in different contexts [Fig. 6i,j]. Interestingly, embryo-specific escapees show variable responses to Xist upregulation with the majority of genes showing a reduction in allelic ratio but also a subset of them being mostly unaffected [Fig. 6i,j]. A closer examination of these latter genes revealed that two of these them, Rho5x and Fthl17f (also known as Gm5635), are imprinted genes only expressed from the Xp66,67 and have previously been seen to be expressed on the Xp at this stage of development38 [Fig. 6j]. Finally, as observed in NPCs, facultative escapees (including NPC-specific escapees) are the most efficiently silenced genes upon Xist upregulation in E4.5 embryos [Fig. 6i, j].
Thus, these experiments confirm our in vitro findings and prove that Xist RNA levels can control the degree of escape from XCI in vivo for the majority of escapees although constitutive escapees are affected to a lesser extent.
DISCUSSION
Our study demonstrates that Xist RNA levels can directly modulate expression levels of all X-linked escapees in differentiated cells, via Xist’s key silencing partner, SPEN, and beyond the developmental time window previously assumed to be Xist’s main time of action. These findings pave the way to understanding how natural fluctuations in Xist expression levels, that may arise during development, in adult tissues or pathological situations such as in cancer, might impact X-linked escapee gene expression and protein dosage.
Recent work in humans and mice showed that deletion or knock down of Xist/XIST, for example in human mammary stem cells48, or in the murine hematopoietic system53, can lead to epigenetic changes that have small but significant effects on X-linked gene expression. Even a small increase in X-linked gene expression can result in important phenotypic consequences, for example on mammary cell differentiation potential, leading to female-specific cancer development48,53. This is illustrated by the recent example of MED14, a facultative Xi escapee in both mouse and humans25,68, the up-regulation of which from the Xi results in increased levels of Mediator complex with major consequences on mammary stem cell differentiation and breast cancer48. Similarly, the re-activation of a subset of X-linked escapees leads to female-specific leukaemia in mice53.
We now provide direct evidence that the levels of Xist RNA participate in the regulation of X-linked escapees in a post-developmental context, potentially throughout life. This implies that natural genetic variation at the Xist/XIST locus, or its trans regulators, might impact the levels of Xist/XIST expression between individuals, as well as between cells of the same individuals when random XCI is taken into account. Given our findings, Xist/XIST RNA levels are therefore likely to be critical for the establishment and maintenance of sex-specific regulatory programs that when misregulated may lead to phenotypic consequences including sex-biased diseases.
Although previous work in human cells has indicated that XIST might be able to induce some degree of gene silencing in adult cells, these studies did not look into the impact of dialling up Xist levels to induce silencing of facultative and even constitutive escapees. In one study, the ectopic induction of a human XIST cDNA from an autosome in a cancer cell line led to repression of a flanking reporter gene69 and in another study, XIST was shown to re-silence genes that had been partially re-activated on the X chromosome in adult human B cells, if XIST was first switched off and then back on using reversible CRISPR interference49. Here we directly show that escapees which have either lost a repressive chromatin state (facultative escapees) or never acquired it (constitutive escapees) during differentiation, are still fully susceptible both to Xist-SPEN mediated transcriptional repression in differentiated cells and, in the case of facultative escapees, to the subsequent acquisition of stable epigenetic marks, such as DNA methylation, over time. Thus, although the prevailing view has been that Xist RNA can only act in adult cells via its influence on the Polycomb machinery to reinforce maintenance12, our work demonstrates that Xist’s influence on escapees in differentiated cells is via direct SPEN-mediated gene silencing.
Our study also provides important new insights into the interplay between the 3D topology of the Xi and the transcriptional activity of escapees. We show that TAD-like domains encompassing clusters of escapees on the Xi, as previously described in Giorgetti et al 201657, are in fact a direct consequence of gene activity and open chromatin as they are eliminated by gene repression and reappear upon re-establishment of transcription. We show that this reversibility in 3D chromatin organisation is not simply a consequence of higher levels of Xist RNA coating the Xi, but strictly depends on Xist’s SPEN-mediated silencing function. Xist RNA is therefore capable of driving the structural reorganisation of the X chromosome only by inducing gene silencing, and this feature is not limited to early development. Whether the presence of TAD-like structures on the Xi facilitates the escape or reactivation of genes during development or later on in adult tissue is not yet clear. However, our findings show that increased levels of Xist RNA in post-XCI cells can overrule this layer of epigenetic regulation.
Our work also reveals distinctive differences between facultative and constitutive escapees. Although expression of all escapees is affected by increased Xist RNA levels, constitutive escapees are less susceptible and maintain the capacity to resist full XCI, both in vitro and in vivo. Constitutive escapees are thought to be highly dosage-sensitive and presumably must need to be protected from complete Xist-mediated silencing not only during development, when XCI is first initiated, but also in adult tissues, as any increase in Xist RNA levels could potentially lead to their inactivation with deleterious effects on tissue homeostasis. Indeed, the dosage regulation of constitutive escapees that have retained a Y-chromosome homolog during the evolution of sex chromosomes is thought to be absolutely critical as these genes are involved in many fundamental functions such as chromatin regulation, protein translation and ubiquitination70,71.
Notably, the expression levels of constitutive escapees do get affected by increased Xist RNA and this is likely to occur in adult tissues too, with potential consequences on tissue homeostasis. However, the capacity to ultimately override prolonged Xist upregulation, suggest that these genes are likely to have evolved gene-specific strategies that allow them to avoid the repressive epigenetic machinery brought to the Xi by Xist and SPEN. On the other hand, facultative escape is highly variable and likely not driven by the same evolutionary pressures that ensure biallelic expression of constitutive escapees. In particular, whether facultative escape reflects inefficient gene silencing and/or XCI maintenance, or is actually needed (purposeful) is still not fully understood. In fact, there may be genomic and epigenetic features within clusters of escapees that make these regions of the X chromosome more prone to unstable XCI and reactivation. On the other hand, the fact that it is mostly the same subset of facultative escapees that variably resist XCI or become reactivated on the Xi in different tissues or individuals, suggests that higher expression levels of this subset of genes that cluster together on the X chromosome may confer an advantage to XX individuals in certain physiological contexts or under stressful environmental conditions.
Finally, as prolonged high levels of Xist RNA lead to irreversible inactivation of these genes, we speculate that the capacity of facultative genes to become reactivated and to escape XCI in some contexts may be determined by the levels of Xist RNA to which they were exposed at the onset of XCI. In fact, during embryonic development and ESC differentiation, XCI is not perfectly synchronous28 and different cells will be exposed to different levels of Xist RNA41, potentially setting a threshold for facultative escapees to remain susceptible to varying Xist RNA levels in adult somatic cells. Accordingly, the modulation of their expression levels following changes in Xist RNA expression may underlie the plasticity of this subset of X-linked genes to allow for fine tuning gene dosage regulation in different conditions. Although further studies are necessary to reveal the exact consequences of varying Xist RNA levels to tissue homeostasis, having unveiled the role of Xist RNA in tuning the dosage of escapees provides the basis to ultimately explore the role of this non-coding RNA in disease contexts, and to define the impact of variation in the expression of specific escapee genes on pathological phenotypes, both as biomarkers but also with the perspective of therapeutic strategies that control specific X-linked gene dosage.
METHODS
Cell Culture
Mouse ES cells TX1072 (Mus musculus castaneus (Cast/Eij) x Mus musculus domesticus (C57BL/6)) have been previously derived in the lab59. Cells were cultured on gelatine-coated (0.1 % gelatine in 1X-PBS) cell culture dish in 2i-containing ESC media (DMEM, 15% FBS, 0.1 mM β-mercaptoethanol, 1,000 U/mL−1 leukaemia inhibitory factor (LIF), CHIR99021 (3 μM), and PD0325901 (1 μM)). NPC differentiation and subcloning was performed as previously described56. NPC clones CL30 and CL31 carrying endogenous SPEN alleles tagged with AID-GFP have been previously generated in the lab2. NPCs were cultured on gelatine-coated (0.1 % gelatine in 1X-PBS) cell culture dish in NPC media (N2B27 media supplemented with with FGF2 (10 ng/mL) and EGF (10 ng/mL, both Peprotech)).
Cell treatments
Xist expression in TX1072 was induced by addition of doxycycline (1 μg/mL) to the NPC media. Culture media supplemented with doxycycline was renewed every 24h. For doxycycline washout, doxycycline-containing media was removed, and cells were refreshed with doxycycline-free culture media. Auxin-mediated depletion of SPEN was achieved by supplementing the culture media with Auxin (Sigma) at the concentration of 500 μM, as previously described2. Auxin-containing media was renewed every 24h.
RNA fluorescence in situ hybridization (FISH)
RNA-FISH on NPCs and preimplantation embryos was performed as previously described72,73. NPCs were dissociated using Accutase (Invitrogen), and attached to Poly-L-Lysine (Sigma) coated coverslips for 10 min. Cells were fixed with 3% paraformaldehyde in PBS for 10 min at room temperature and permeabilized with ice-cold permeabilization buffer (1X-PBS, 0.5% Triton X-100, 2 mM vanadyl-ribonucleoside complex (New England Biolabs)) for 4 min on ice. Coverslips were stored in 70% ethanol at −20 °C. Cells were dehydrated in increasing ethanol concentrations (80%, 95%, 100%) and air dried quickly. Probes were prepared from plasmid p510. Probes were fluorescently labelled by nick translation (Abbott). We used dUTP labelled with ATTO-488 green (Jena Bioscience) or Cy5 (Merck). Labelled probes were co-precipitated with mouse Cot-1 DNA (Thermo Fisher) in the presence of ethanol and salt, resuspended in formamide, denatured at 75 °C for 8 min and competed at 37 °C for 40 min. Probes were hybridised in FISH hybridization buffer (50% formamide, 20% dextran sulfate, 2X SSC, 1 μg/μL BSA (New England Biolabs), 10 mM vanadyl-ribonucleoside complex) at 37 °C overnight. The next day coverslips were washed three times for 5 min with 50% formamide in 2X SSC at 42 °C, and three times for 5 min with 2X SSC at room temperature. DAPI (0.2 mg/mL was added to the second wash and coverslips were mounted with Vectashield (Vectorlabs). For E3.5 and E4.5 embryos we followed a similar protocol with these modifications: coverslips were incubated in Denhardt’s solution (3X SSC, 0.2 mg/ml BSA, 0.2 mg/ml Ficoll-400, and 0.2 mg/ml polyvinylpyrrolidone (PVP40) in water) for 3 hours at 65 °C, followed by incubation in 3:1 methanol/glacial acetic acid solution for 20 min at room temperature and in 0.25% (v/v) glacial acetic acid 0.1 M triethanolamine solution for 10 min at room temperature. The zona pellucida was removed by treatment with acidified Tyrode’s solution. E3.5 embryos were permeabilized for 13 min and E4.5 for 20 min, respectively. Images were acquired with an OLYMPUS iXplore Spin-SR Spinning Disk microscope with 60x or 100x objective. Images were analysed with ImageJ software (Fiji).
NPC RNA extraction and RNA sequencing
RNA was extracted from > 1M NPCs using the RNeasy kit and on-column DNAse digestion (Qiagen). RNA integrity was measured using the Bioanalyzer Nano Kit. Only high-quality RNA was used for subsequent library preparation using the NEBNext Poly(A) mRNA Magnetic Isolation Module (E7490L) and NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (E7760L, New England Biolabs (NEB), Ipswich, MA, USA) implemented on the liquid handling robot Beckman i7. Obtained libraries that passed the QC step were pooled in equimolar amounts; and the pools were loaded on the Illumina sequencer NexSeq500 or NextSeq2000 and sequenced bi-directionally, generating ~500 million paired-end reads, each 75 bases long. For the 129/Sv x Cast-EiJ NPCs, RNA was quantified with Qubit RNA Broad Range assay (Invitrogen, Q10211). RNA was sent to Novogene for RNA integrity and purity quality check followed by Eukaryotic strand-specific mRNA (with PolyA-enrichment) library preparation. Libraries were then pooled and sequenced on an Illumina Novaseq 6000 platform for 2×150 bp paired-end reads for 80 million reads total per sample.
Mouse crosses, embryos collection and whole-embryo RNA sequencing
All experimental design and procedure were performed in agreement with the rules and regulations of the Institutional Animal Care and Use Committee (IACUC) under protocol number 019-03-21EH. Embryos were derived from natural mating between C57BL/6 TX males Xptet/Y; R26rtTA/WT (whole embryo RNA-seq) or Xptet/Y; R26rtTA/rtTA (RNA FISH) with wild type JF1 females. Embryos were harvested at E2.5 and E3.5 and cultured in vitro in G-1 PLUS media (Vitrolife) in the presence of 10 μg/mL Doxycycline for 24 hours. For RNA FISH analysis, approximately half of the collected embryos at each time point were grown in culture medium without Doxycycline. The sex of the embryos was determined either by Xist RNA-FISH or by PCR after RNA-seq libraries preparation. Single embryos were picked and washed three times with transfer buffer (1X- PBS, 0.4% BSA) and transferred into 0.2 ml PCR tubes containing 2μl of lysis buffer (0.7% Triton X-100, 2U/μl RNasin (Promega), 1μl of oligo-dT30VN primer (10 μM 5’-aagcagtggttatcaacgcagagtact30vn-3’) and 1 μl of 10 mM dNTP mix (Thermo Fisher). Illumina libraries were prepared by using a modified smart-seq2 protocol [Picelli 2014] using SuperScript IV RT and tagmentation procedure as previously described [Henning 2018]. The RT reaction mix was as follows: 2 μl SSRT IV 5x buffer; 0.5 μl 100 mM DTT; 2 μl 5 M betaine; 0.1 μl 1 M MgCl2; 0.25 μl 40 U/μl RNAse inhibitor; 0.25 μl SSRT IV; 0.1 μl 100 uM TSO, 1.15 μl RNase-free H2O. RT thermal conditions: 52 °C 15 min, 80 °C 10 min. cDNA was generated using 16 PCR cycles. The cDNA cleanup (0.6x SPRI ratio) was carried out omitting the ethanol wash steps and the elution volume was 13 μl of H2O. For tagmentation, the sample input was normalized to 0.2 ng/μl. Obtained libraries that passed the QC step were pooled in equimolar amounts. After library preparation the sex and genotype of each embryo was assessed by PCR for rtTA (rtTA_F, acgccttagccattgagatg, rtTA_R, tctttagcgacttgatgctc); Xist (Xist_F, ggttctctctccagaagctaggaa, Xist_R, tggtagatggcattgtgtattatatg), and Eif2s3y (Eif2s3y_F, aattgccaggttattttcattttc, Eif2s3y_R, agttcagtggtgcacagcaa). Libraries were sequenced at 50 bp paired-end on NextSeq 2000 platform.
Capture Hi-C
Capture Hi-C was performed as previously described62. Two arrays of biotinylated RNA probes were designed to tile 3 Mb targets on the mouse X chromosome (Hcfc1-Mecp2 cluster; ChrX:72,590,000 – 75,430,000; Kdm5c cluster; ChrX: 150,210,000 – 153,045,000).
Enzymatic Methyl-seq (EM-Seq)
Genomic DNA (gDNA) from >1M NPC was extracted using column-based DNeasy Blood & Tissue Kit (Qiagen). DNA integrity was tested on a 0.8% agarose gel and high-quality gDNA was used to prepare libraries according to the NEBNext® Enzymatic Methyl-seq Kit following the section for large insert libraries with minor modifications. A total of 55–100 ng of gDNA was used per library, including a spike-in of pUC and Lambda DNA as a control for methylation efficiency. Samples were fragmented using the Covaris S2 System to achieve an average fragment size of 350–400 bp and barcoded using 5 PCR cycles for 100 ng input and 6 PCR cycles for 55 ng input. The obtained libraries were pooled in equimolar amounts and sequenced at 100 bp paired-end on a NextSeq 2000 platform.
Targeted capture methylation sequencing (EM-Cap)
Genomic DNA (gDNA) samples used for EM-Seq were used for EM-Cap as previously described65 with minor adjustments. For the final library amplification the cycle number was increased to 14. The same arrays of biotinylated RNA probes designed for the Capture Hi-C experiments were used.
ATAC-seq
ATAC-seq was performed following the Omni-ATAC protocol74, that has been shown to reduce the number of mitochondrial reads while increasing the signal-to-noise ratio. 25,000 cells were collected, lysed for 3 min on ice in lysis buffer (10mM Tris-HCl pH.5, 5M NaCl, 1M MgCl2, 0.1% NP-40, 0.1% Tween-20, 0.01% Digitonin), washed in wash buffer (10mM Tris-HCl pH.5, 5M NaCl, 1M MgCl2, 0.1% Tween-20), and spun down at 500 RCF at 4°C for 10 min. Pellets were resuspended in 50 μL of transposition reaction (2X TD buffer, 1X PBS, 0.1% Tween-20, 0.1% Digitonin, 5μL of Illumina Tn5 transposase) and incubated for 30 min at 37°C with 1,000 rpm agitation. DNA was isolated with Zymo DCC5 kit and eluted in 21 μL of elution buffer. DNA samples were initially amplified by 5 cycles of PCR, followed by a variable number of additional amplification cycles estimated by qPCR for each sample. PCR products were purified using the Zymo DCC5 kit and eluted in 20 μL of water. A two-size selection of fragments was performed using 0.5x and 1.3x volume of AMPure XP beads (Beckman Coulter). Libraries were quantified and analyzed using Qubit and Tapestation assays, before preparing equimolar dilutions. Paired-end sequencing was performed on NextSeq 500 (Illumina).
BIOINFORMATICS
Allele-specific preprocessing of RNA-Sequencing data
All steps for the preprocessing of RNA-Sequencing data can be reproduced using a nextflow pipeline available at https://github.com/yuviaapr/allele-specific_RNA-seq. Reads were trimmed using trim_galore (v0.6.6). To construct reference genomes for allele-specific mapping, genomes in which known heterozygous variants (https://ftp.ebi.ac.uk/pub/databases/mousegenomes/REL-2112-v8-SNPs_Indels/mgp_REL2021_snps.vcf.gz) were masked by the ambiguous base N were constructed using SNPsplit (SNPsplit_genome_preparation script, v0.5.0) and converted to STAR references (STAR v2.5.3a). For the E6, CL30/CL30.7 and CL31/CL31.16, the mm10 genome (GRCm38) was used. For the embryo and 129/Sv x CAST/EiJ cell lines, the mm11 genome was used (GRCm39). Reads were aligned to the N-masked genomes using the options --sjdbOverhang 99 --outFilterMultimapNmax 1 --outFilterMismatchNmax 999 --outFilterMismatchNoverLmax 0.06 --alignIntronMax 500000 --alignMatesGapMax 500000 --alignEndsType. Reads mapping to the mitochondrial genome were removed and split into parental genotypes using SNPsplit and known heterozygous variants. Genelevel read counts for each haplotype and without allelic resolution were derived using featureCounts (v2.0.1).
Computation of allelic ratios in RNA-Seq for escapee definition
Allele-specific expression per gene was calculated from genotype-assigned read counts. First, lowly expressed genes with an average allelic read count < 10 were excluded (summing both haplotypes). Escape of an X-linked gene was generally quantified as the fraction of read counts on the inactivated X against the total read count across both active and inactive X (Xi / (Xi + Xa), allelic ratio, also known as d-score). Genes were considered as escaping when the allelic ratio exceeded 0.1 (10% of expression from the inactive X). As the causal gene of XCI, Xist was not considered an escapee. A small number of other genes showed allelic ratios > 0.8, which likely represents either strain-specific expression or technical artefacts due to erroneous mapping or SNPs with non-reference genotypes, rather than genuine expression largely restricted to the Xi. These genes were excluded for subsequent analysis. For all analysis of escape in the E6 cell line, we used the set of 133 genes (134 including Xist) which showed an allelic ratio > 0.1 in all untreated replicates. The use of N-masking of the genome should reduce mapping bias at SNP positions. Furthermore, we focus on relative changes (reductions) in allelic ratios, which should be unaffected by technical artefacts.
Escapee meta-analysis
To obtain a consensus of escaping genes from the literature, we performed a meta-analysis of papers that used genome wide expression profiling to derive escapees. For each study (Supplementary Table 1), we considered the genes defined as escapees or silenced by the experimental and analysis methodology used in that paper. In each study, a gene is therefore considered “escaping”, “silenced” or “not detected”. We then classified genes as “constitutive escapees”, if they were detected in at least 3 and escaped in more than 50% of the studies. We defined genes as “facultative escapees”, if they were escaping in less than 50% of studies or were only detected in less than 3 (but escaped in at least one study). Finally, we defined genes as “silenced”, if they were not escaping in any assayed study.
Differential allelic imbalance analysis
To test for differential allelic imbalance (differences in escape between conditions), we employed binomial generalized linear models (R package stats, v4.2.0). We modelled the number of reads mapping to the inactive X as binomially distributed with the formula (k, n) ~ 1 + treatment and tested for the significance of a treatment coefficient using a Wald test. P-values were adjusted using the Holm-Bonferroni method.
Modelling of escape trajectories
We used non-linear parametric regression to fit an exponential decay curve to the allelic ratios after Xist overexpression. Specifically, we used the nls function (R, stats) to fit the allelic ratios r = Xi / (Xi + Xa) with the exponential decay function r ~ a * exp(- k * t) + b, where t represents the number of days of doxycycline treatment, a is a scaling parameter of the decay, b allows for an asymptotic offset and k specifies the decay constant. In particular, k relates to the speed (half-life) of silencing loss by t1/2 = - ln(0.5)/k and b quantifies whether there is residual escape after prolonged Xist overexpression. We also fit the same model without b, to test which genes showed evidence for residual escape as opposed to full silencing. After excluding all genes with a regression R^2 < 0.3 for both fits, we used the Bayesian Information Criterion to classify whether genes showed residual escape.
Definition of escapee clusters
To define locally close groups of escapees on the X-chromosome, we iterated through all escapees on the X, grouping genes into one “cluster” if the gene start position was within 100kb of each other, and splitting whenever this was not the case. This approach partitioned the escapee set into 11 groups of 3 or more genes (with 3 – 14 escapees) and 57 singles or pairs.
Differential expression analysis
We used DESeq2 (R, v1.36.0) to test both haplotype-specific and total expression counts for differential expression using standard settings, using the formula ~ Treatment and adjusting p-values using the BenjaminiHochberg correction.
Allele-specific analysis of DNA methylation data
Processing of DNA methylation was performed using the methylseq nextflow pipeline with the --emseq option (v2.3.0, NextFlow v22.10.6). Reads were trimmed using TrimGalore! (v0.6.7) and aligned to the same N-masked genome (GRCm38) using bismarck (v0.24.0), and used SNP_split (v0.5.0) to assign mapped reads to parental genomes, similar to the RNA-Seq data. We finally used bismark_methylation_extractor from the bismarck software to generate base-level methylation counts for both haplotypes. We retrieved genomic coordinates of CpG islands (http://genome.ucsc.edu/cgi-bin/hgTrackUi?g=cpgIslandExt), gene bodies and promoters (2kb up-to 200bp downstream of transcription start sites) (EnsDb.Mmusculus.v79, v2.99.0). To quantify DNA methylation in promoters, we used regions of accessible chromatin defined by ATAC-Seq data in matched cell lines (see below) if they overlapped with annotated promoter regions. We quantified average methylation values across per-base methylation values b = methylated / (methylated + unmethylated) in the regions of interest.
Allele-specific Capture Hi-C analysis
Allele-specific Capture Hi-C analysis was performed using the Hi-C Pro pipeline (v2.11.4)75 as previously described62. Paired-end reads were first independently aligned using bowtie2 to the same N-masked genome reference. Read pairs were then assigned to either C57BL-6J or CAST-EiJ genomes and allele-specific BAM files for downstream analysis are generated. Low-quality reads, multiple hits, singletons and read pairs which do not map to the same genotype were then removed. Further filtering for valid interactions, which excludes reads outside of the captured region, was performed and only valid pairs were used to build the normalized contact maps at a 10 kb resolution with the cooler package (v0.8.9). Insulation scores were calculated using the cooltools package (v0.3.2)76 and boundaries were deduced from it a the local minimas. All data was visualized using pyGenomeTracks77.
Allele-specific ATAC-seq analysis
All steps for the preprocessing of ATAC-seq data can be reproduced using a nextflow pipeline available at https://github.com/yuviaapr/allele-specific_ATAC-seq. Briefly, initial quality checks of the raw FASTQ files were performed using FastQC (v0.11.9). Reads were trimmed using Trim Galore (v0.6.3). Reference genome for allele-specific mapping, was constructed as described for the allele-specific RNA-seq analysis, and used to generate a bowtie index. Paired-end reads were aligned using bowtie2 (v2.3.4.1) to the N-masked genome index with the following parameters: --very-sensitive -X 2000. Duplicates were removed using Picard Tools (v2.20.8) before downstream analyses. Peaks were called using MACS2 (v2.2.7.1) using the following parameters: -g mm --buffer-size 100 -q 0.01 --keep-dup all --min-length 100 --format BAMPE --nomodel. Consensus peaks were generated using the “dba.peakset” function from the DiffBind Bioconductor R package (v3.8.4), with the requirement that peaks should be present in at least two BAM files. Blacklist regions (from ENCODE for BSgenome.Mmusculus.UCSC.mm10) were removed using the dba.blacklist function, and the raw counts for the resulting consensus peak set were generated using the dba.count function using summits=FALSE. Peak counts were normalised using the dba.normalize function, with default settings. Differential accessibility analysis between the split BAM files coming from the Xi and Xa was performed using the dba.analyze function with methods=DBA_DESEQ2 (calling the DESeq2 Bioconductor R package (v1.38.3) in the background). Peaks were annotated to their nearest gene using the ChIPseeker Bioconductor R package (v1.34.1) using the mm10 genome from the TxDb.Mmusculus.UCSC.mm10.knownGene Bioconductor R package (v3.10.0).
Processing of embryo RNA-Seq data
The embryo RNA-Sequencing data was pre-processed as described above (Allele-specific preprocessing of RNA-Sequencing data), using the SNPs between C57BL/6 and JF1 mice (https://ftp.ebi.ac.uk/pub/databases/mousegenomes/REL-2112-v8-SNPs_Indels/mgp_REL2021_snps.vcf.gz). To confirm the annotated genotypes of the embryos, the rtTA transgene was included in the reference genome, and any embryo with >50 mapped transgene reads was considered rtTA-positive. For developmental staging, principal component analysis (prcomp, stats v4.2.0) was performed on total read counts after size-factor normalization (estimateSizeFactors, DESeq2, v1.36.0) and subsetting on highly variable genes (getTopHVGs, scran, v1.24.1). The first principal component separated embryo stages as determined by morphological staging and was used as a developmental pseudotime. For the allelic analysis, genes were considered escapees if they showed an allelic ratio > 0.1 in at least 50% of embryos. Genes were annotated into escape categories as in the meta-analysis and classified as “embryo-specific” if they did not escape in E6 and/or were not annotated as escapees in the meta-analysis.
ACKNOWLEDGMENTS
This work was funded by an ERC Advanced Investigator award to E.H. (XPRESS - AdG671027), the European ITN Innovative and Interdisciplinary Network “ChromDesign”, under the Marie Skłodowska-Curie Grant agreement 813327 to E.H., a Marie Skłodowska-Curie Actions Individual Fellowship to A.L. (IF-838408); Core funding from the German Cancer Research Center (O.S & D.T.O) and the European Molecular Biology Laboratory (O.S), the European Research Council (grant agreement IDs 810296 / DECODE to O.S. and 788937 / CTCFStableGenome and 615584 / EvoGeneticsTFBinding to D.T.O), Wellcome Investigator Award (202878_Z_16_Z to D.T.O.), as well as the Bundesministerium für Bildung und Forschung Germany, project MERGE, Förderkennzeichen 031L0174C (to O.S.). H.Y.C. is an Investigator of the Howard Hughes Medical Institute and he is supported by NIH RM1-HG007735. We thank T. Pollex for critical and thoughtful reading of the manuscript, P. Ginno for discussion and members of the Heard, Stegle and Odom lab for discussion. We also thank Vladimir Benes and the Genomics Core Facility at EMBL (Heidelberg), for support and assistance.
Footnotes
Code availability
Code available upon request
COMPETING INTERESTS
H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences, Orbital Therapeutics, and an advisor of 10x Genomics, Arsenal Biosciences, Chroma Medicine, Exai Bio, and Spring Discovery.
Data availability
RNA-seq, Capture Hi-C, ATAC-seq and Methyl-seq data generated in this study have been deposited in the Gene Expression Omnibus under accession number GSEXXXXXX
REFERENCES
- 1.Loda A, Heard E. Xist RNA in action: Past, present, and future. PLoS Genet. 2019;15(9):e1008333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dossin F, Pinheiro I, Żylicz JJ, et al. SPEN integrates transcriptional and epigenetic control of X-inactivation. Nature. 2020;578(7795):455–460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Naqvi S, Godfrey AK, Hughes JF, Goodheart ML, Mitchell RN, Page DC. Conservation, acquisition, and functional impact of sex-biased gene expression in mammals. Science. 2019;365(6450). doi: 10.1126/science.aaw7317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Oliva M, Muñoz-Aguirre M, Kim-Hellmuth S, et al. The impact of sex on gene expression across human tissues. Science. 2020;369(6509). doi: 10.1126/science.aba3066 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Melé M, Ferreira PG, Reverter F, et al. The human transcriptome across tissues and individuals. Science. 2015;348(6235):660–665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yang X, Schadt EE, Wang S, et al. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006;16(8):995–1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tukiainen T, Villani AC, Yen A, et al. Corrigendum: Landscape of X chromosome inactivation across human tissues. Nature. 2018;555(7695):274. [DOI] [PubMed] [Google Scholar]
- 8.Berletch JB, Yang F, Xu J, Carrel L, Disteche CM. Genes that escape from X inactivation. Hum Genet. 2011;130(2):237–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Souyris M, Cenac C, Azar P, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018;3(19). doi: 10.1126/sciimmunol.aap8855 [DOI] [PubMed] [Google Scholar]
- 10.Souyris M, Mejía JE, Chaumeil J, Guéry JC. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin Immunopathol. 2019;41(2):153–164. [DOI] [PubMed] [Google Scholar]
- 11.Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442–447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Loda A, Collombet S, Heard E. Gene regulation in time and space during X-chromosome inactivation. Nat Rev Mol Cell Biol. 2022;23(4):231–249. [DOI] [PubMed] [Google Scholar]
- 13.McHugh CA, Chen CK, Chow A, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521(7551):232–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chu C, Zhang QC, da Rocha ST, et al. Systematic discovery of Xist RNA binding proteins. Cell. 2015;161(2):404416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Minajigi A, Froberg J, Wei C, et al. Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. Science. 2015;349(6245). doi: 10.1126/science.aab2276 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Moindrot B, Cerase A, Coker H, et al. A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing. Cell Rep. 2015;12(4):562–572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Monfort A, Di Minin G, Postlmayr A, et al. Identification of Spen as a Crucial Factor for Xist Function through Forward Genetic Screening in Haploid Embryonic Stem Cells. Cell Rep. 2015;12(4):554–561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Carrel L, Brown CJ. When the Lyon(ized chromosome) roars: ongoing expression from an inactive X chromosome. Philos Trans R Soc Lond B Biol Sci. 2017;372(1733). doi: 10.1098/rstb.2016.0355 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Posynick BJ, Brown CJ. Escape From X-Chromosome Inactivation: An Evolutionary Perspective. Front Cell Dev Biol. 2019;7:241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Balaton BP, Cotton AM, Brown CJ. Derivation of consensus inactivation status for X-linked genes from genome-wide studies. Biol Sex Differ. 2015;6:35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wainer Katsir K, Linial M. Human genes escaping X-inactivation revealed by single cell expression data. BMC Genomics. 2019;20(1):201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zito A, Roberts AL, Visconti A, et al. Escape from X-inactivation in twins exhibits intra- and inter-individual variability across tissues and is heritable. PLoS Genet. 2023;19(2):e1010556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Patrat C, Okamoto I, Diabangouaya P, et al. Dynamic changes in paternal X-chromosome activity during imprinted X-chromosome inactivation in mice. Proc Natl Acad Sci U S A. 2009;106(13):5198–5203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Berletch JB, Ma W, Yang F, et al. Escape from X inactivation varies in mouse tissues. PLoS Genet. 2015;11(3):e1005079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Marks H, Kerstens HHD, Barakat TS, et al. Dynamics of gene silencing during X inactivation using allele-specific RNA-seq. Genome Biol. 2015;16(1):149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Calabrese JM, Sun W, Song L, et al. Site-specific silencing of regulatory elements as a mechanism of X inactivation. Cell. 2012;151(5):951–963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Corbel C, Diabangouaya P, Gendrel AV, Chow JC, Heard E. Unusual chromatin status and organization of the inactive X chromosome in murine trophoblast giant cells. Development. 2013;140(4):861–872. [DOI] [PubMed] [Google Scholar]
- 28.Cheng S, Pei Y, He L, et al. Single-Cell RNA-Seq Reveals Cellular Heterogeneity of Pluripotency Transition and X Chromosome Dynamics during Early Mouse Development. Cell Rep. 2019;26(10):2593–2607.e3. [DOI] [PubMed] [Google Scholar]
- 29.Snell DM, Turner JMA. Sex Chromosome Effects on Male-Female Differences in Mammals. Curr Biol. 2018;28(22):R1313–R1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Fang H, Deng X, Disteche CM. X-factors in human disease: impact of gene content and dosage regulation. Hum Mol Genet. 2021;30(R2):R285–R295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N. Requirement for Xist in X chromosome inactivation. Nature. 1996;379(6561):131–137. [DOI] [PubMed] [Google Scholar]
- 32.Marahrens Y, Panning B, Dausman J, Strauss W, Jaenisch R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev. 1997;11(2):156–166. [DOI] [PubMed] [Google Scholar]
- 33.Wutz A, Jaenisch R. A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell. 2000;5(4):695–705. [DOI] [PubMed] [Google Scholar]
- 34.Splinter E, de Wit E, Nora EP, et al. The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA. Genes Dev. 2011;25(13):1371–1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Brown CJ, Willard HF. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature. 1994;368(6467):154–156. [DOI] [PubMed] [Google Scholar]
- 36.Csankovszki G, Panning B, Bates B, Pehrson JR, Jaenisch R. Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation. Nat Genet. 1999;22(4):323–324. [DOI] [PubMed] [Google Scholar]
- 37.Hong R, Lin B, Lu X, et al. High-resolution RNA allelotyping along the inactive X chromosome: evidence of RNA polymerase III in regulating chromatin configuration. Sci Rep. 2017;7:45460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Borensztein M, Syx L, Ancelin K, et al. Xist-dependent imprinted X inactivation and the early developmental consequences of its failure. Nat Struct Mol Biol. 2017;24(3):226–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Deng Q, Ramsköld D, Reinius B, Sandberg R. Single-cell RNA-seq reveals dynamic, random monoallelic gene expression in mammalian cells. Science. 2014;343(6167):193–196. [DOI] [PubMed] [Google Scholar]
- 40.Barros de Andrade E Sousa L, Jonkers I, Syx L, et al. Kinetics of Xist-induced gene silencing can be predicted from combinations of epigenetic and genomic features. Genome Res. 2019;29(7):1087–1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Pacini G, Dunkel I, Mages N, et al. Integrated analysis of Xist upregulation and X-chromosome inactivation with single-cell and single-allele resolution. Nat Commun. 2021;12(1):3638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Loda A, Brandsma JH, Vassilev I, et al. Genetic and epigenetic features direct differential efficiency of Xist-mediated silencing at X-chromosomal and autosomal locations. Nat Commun. 2017;8(1):690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Żylicz JJ, Bousard A, Žumer K, et al. The Implication of Early Chromatin Changes in X Chromosome Inactivation. Cell. 2019;176(1–2):182–197.e23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Almeida M, Pintacuda G, Masui O, et al. PCGF3/5–PRC1 initiates Polycomb recruitment in X chromosome inactivation. Science. 2017;356(6342):1081–1084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Pintacuda G, Wei G, Roustan C, et al. hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing. Mol Cell. 2017;68(5):955–969.e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Żylicz JJ, Heard E. Molecular Mechanisms of Facultative Heterochromatin Formation: An X-Chromosome Perspective. Annu Rev Biochem. 2020;89:255–282. [DOI] [PubMed] [Google Scholar]
- 47.da Rocha ST, Gendrel AV. The influence of DNA methylation on monoallelic expression. Essays Biochem. 2019;63(6):663–676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Richart L, Picod-Chedotel ML, Wassef M, et al. XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation. Cell. 2022;185(12):2164–2183.e25. [DOI] [PubMed] [Google Scholar]
- 49.Yu B, Qi Y, Li R, Shi Q, Satpathy AT, Chang HY. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell. 2021;184(7):1790–1803.e17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Yang L, Kirby JE, Sunwoo H, Lee JT. Female mice lacking Xist RNA show partial dosage compensation and survive to term. Genes Dev. 2016;30(15):1747–1760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Yang L, Yildirim E, Kirby JE, Press W, Lee JT. Widespread organ tolerance to Xist loss and X reactivation except under chronic stress in the gut. Proc Natl Acad Sci U S A. 2020;117(8):4262–4272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Yang T, Ou J, Yildirim E. Xist exerts gene-specific silencing during XCI maintenance and impacts lineage-specific cell differentiation and proliferation during hematopoiesis. Nat Commun. 2022;13(1):4464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yildirim E, Kirby JE, Brown DE, et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell. 2013;152(4):727–742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Adrianse RL, Smith K, Gatbonton-Schwager T, et al. Perturbed maintenance of transcriptional repression on the inactive X-chromosome in the mouse brain after Xist deletion. Epigenetics Chromatin. 2018;11(1):50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Marion-Poll L, Forêt B, Zielinski D, et al. Locus specific epigenetic modalities of random allelic expression imbalance. Nat Commun. 2021;12(1):5330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Gendrel AV, Attia M, Chen CJ, et al. Developmental dynamics and disease potential of random monoallelic gene expression. Dev Cell. 2014;28(4):366–380. [DOI] [PubMed] [Google Scholar]
- 57.Giorgetti L, Lajoie BR, Carter AC, et al. Structural organization of the inactive X chromosome in the mouse. Nature. 2016;535(7613):575–579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434(7031):400–404. [DOI] [PubMed] [Google Scholar]
- 59.Schulz EG, Meisig J, Nakamura T, et al. The two active X chromosomes in female ESCs block exit from the pluripotent state by modulating the ESC signaling network. Cell Stem Cell. 2014;14(2):203–216. [DOI] [PubMed] [Google Scholar]
- 60.Savarese F, Flahndorfer K, Jaenisch R, Busslinger M, Wutz A. Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation. Mol Cell Biol. 2006;26(19):7167–7177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Collombet S, Ranisavljevic N, Nagano T, et al. Parental-to-embryo switch of chromosome organization in early embryogenesis. Nature. 2020;580(7801):142–146. [DOI] [PubMed] [Google Scholar]
- 62.Hauth A, Galupa R, Servant N, et al. Deciphering High-Resolution 3D Chromatin Organization via Capture Hi-C. J Vis Exp. 2022;(188). doi: 10.3791/64166 [DOI] [PubMed] [Google Scholar]
- 63.Hellman A, Chess A. Extensive sequence-influenced DNA methylation polymorphism in the human genome. Epigenetics Chromatin. 2010;3(1):11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Cotton AM, Price EM, Jones MJ, Balaton BP, Kobor MS, Brown CJ. Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation. Hum Mol Genet. 2015;24(6):1528–1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Hasegawa K, Nakabayashi K, Ishiwata K, Kasuga Y, Hata K, Tanaka M. A capture methyl-seq protocol with improved efficiency and cost-effectiveness using pre-pooling and enzymatic conversion. BMC Res Notes. 2023;16(1):141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Kobayashi S, Isotani A, Mise N, et al. Comparison of gene expression in male and female mouse blastocysts revealed imprinting of the X-linked gene, Rhox5/Pem, at preimplantation stages. Curr Biol. 2006;16(2):166–172. [DOI] [PubMed] [Google Scholar]
- 67.Kobayashi S, Fujihara Y, Mise N, et al. The X-linked imprinted gene family Fthl17 shows predominantly female expression following the two-cell stage in mouse embryos. Nucleic Acids Res. 2010;38(11):3672–3681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Tukiainen T, Villani AC, Yen A, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550(7675):244–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Chow JC, Hall LL, Baldry SEL, Thorogood NP, Lawrence JB, Brown CJ. Inducible XIST-dependent X-chromosome inactivation in human somatic cells is reversible. Proc Natl Acad Sci U S A. 2007;104(24):10104–10109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Bellott DW, Hughes JF, Skaletsky H, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature. 2014;508(7497):494–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.San Roman AK, Page DC. A strategic research alliance: Turner syndrome and sex differences. Am J Med Genet C Semin Med Genet. 2019;181(1):59–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Chaumeil J, Augui S, Chow JC, Heard E. Combined immunofluorescence, RNA fluorescent in situ hybridization, and DNA fluorescent in situ hybridization to study chromatin changes, transcriptional activity, nuclear organization, and X-chromosome inactivation. Methods Mol Biol. 2008;463:297–308. [DOI] [PubMed] [Google Scholar]
- 73.Ranisavljevic N, Okamoto I, Heard E, Ancelin K. RNA FISH to Study Zygotic Genome Activation in Early Mouse Embryos. Methods Mol Biol. 2017;1605:133–145. [DOI] [PubMed] [Google Scholar]
- 74.Corces MR, Trevino AE, Hamilton EG, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14(10):959–962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Servant N, Varoquaux N, Lajoie BR, et al. HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol. 2015;16:259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Venev S, Abdennur N, Goloborodko A, et al. Open2c/Cooltools: V0.4.1.; 2021. doi: 10.5281/zenodo.5214125 [DOI] [Google Scholar]
- 77.Lopez-Delisle L, Rabbani L, Wolff J, et al. pyGenomeTracks: reproducible plots for multivariate genomic datasets. Bioinformatics. 2021;37(3):422–423. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
RNA-seq, Capture Hi-C, ATAC-seq and Methyl-seq data generated in this study have been deposited in the Gene Expression Omnibus under accession number GSEXXXXXX